Popular     Search Ebooks
            





Powerpoint Slides tags by : trastuzumab >> Browse by Author >> Browse by Institute
 
Her2 positive breast cancer beyond trastuzumab
Author: Anonymous
Institution

Powerpoint Presentation Downloads:   2392
Rating :
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer . Charles E. Geyer, M.D., John Forster, M.Sc., Deborah Lindquist, M.D., Stephen Chan, M.D., C.
Pharmacology of Chemotherapy agents
Author: Anonymous
Institution

Powerpoint Presentation Downloads:   1677
Rating :
Monoclonal antibodiesUnconjugated Rituximab(Rituxan)lymphoma (CD20) Trastuzumab (Herceptin)breast (her2)
Trastuzumab Herceptin Pertuzumab Omnitarg Lapatinib . Erlotinib Tarcev
Author: Anonymous
Institution

Powerpoint Presentation Downloads:   1041
Rating :
Trastuzumab (Herceptin) Pertuzumab (Omnitarg) Lapatinib . Erlotinib (Tarceva) Gefitinib (Iressa) Cetuximab (Erbitux)
CHEMIOTERAPIA PRIMARIA DEL CARCINOMA DELLA MAMMELLA
Author: Anonymous
Institution

Powerpoint Presentation Downloads:   736
Rating :
May 2007 QUART SE minimal residual disease ; 15 N – Trastuzumab for a total of 1 year course + aromatase inhibitor
Update on the 2006 San Antonio Breast Cancer Symposium
Author: Anonymous
Institution

Powerpoint Presentation Downloads:   685
Rating :
30 Jun 2005In patients with HER-2/neu positive and hormone receptor positive advanced breast cancer, the combination of trastuzumab and anastrazole is ...
PPT- Neo Allto- Slideworld Medical Search Engines
Author: Anonymous
Institution

Powerpoint Presentation Downloads:   643
Rating :
PPT- Invasive breast cancer. HER2+ T>2 cm (inflammatory BC excluded) LVEF ? 50% N=450 . FEC ? 3 . 9 weeks . lapatinib . trastuzumab . lapatinib . trastuzumab . 34 weeks
Trastuzumab in Metastatic Breast Cancer
Author: Anonymous
Institution

Powerpoint Presentation Downloads:   510
Rating :
Fever,chills, nausea, vomiting, body pain, rigors, Headache, dizziness, rash, hypotension; Diarrhea 25% Grade 3 hematological toxicity <1% Anaphylaxis/pulmonary
Salvage pathway require HPRT de novo . Salavage . HPRT hybridoma . Sple
Author: Anonymous
Institution

Powerpoint Presentation Downloads:   492
Rating :
Salvage pathway (require HPRT) de novo . Salavage . HPRT + hybridoma . SplenocytesPhase III clinical study of combined trastuzumab and chemotherapy
Alkylating Agents
Author: Anonymous
Institution

Powerpoint Presentation Downloads:   437
Rating :
Trastuzumab (Herceptin) – anti-HER2/neu monoclonal (breast cancer) Bevacizumab (Avastin)anti-VEGF monoclonal (colon cancer) Cetuximab (Erbitux)anti-EGFR
Module II Herceptin® (trastuzumab) in MBC
Author: Anonymous
Institution

Powerpoint Presentation Downloads:   386
Rating :
Module II: Herceptin® (trastuzumab) in MBC
1234567


Medical PowerPoint Templates | Powerpoint Templates | Tags | Contact | About Us | Privacy | FAQ | Blog

© Slideworld